セッション詳細

[WS(O)20]Organ-Specific Immune Diseases

2024年12月4日(水) 15:10 〜 16:25
Room F
Organizers: Kimito Kawahata (St. Marianna University School of Medicine), Haruka Miki (University of Tsukuba)

[WS20-01-O/P]Neutrophil-derived IL-23 p19 monomer suppresses type 17 immunity

Daiya Ohara, Yusuke Takeuchi, Yoonha Lee, Hiroki Mukoyama, Hitomi Watanabe, Gen Kondoh, Keiji Hirota (Institute for Life And Medical Sciences, Kyoto University)

[WS20-02-O/P]Th1-type Tregs induced by interferon-γ limit EAE exacerbation

Masaaki Okamoto1, Naganori Kamiyama4, Takashi Kobayashi4,5, Masahiro Yamamoto1,2,3 (1.Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, 2.Laboratory of Immunoparasitology, WPI Immunology Frontier Research Center, Osaka University, 3.Department of Immunoparasitology, Center for Infectious Disease Education and Research, Osaka University, 4.Department of Infectious Disease Control, Faculty of Medicine, Oita University, 5.Research Center for GLOBAL and LOCAL Infectious Diseases, Oita University)

[WS20-03-O/P]Stage-dependent dynamics of resident memory T cells in lesion sites of multiple sclerosis and neuromyelitis optica spectrum disorders

Fumihiro Yanagimura1,5, Akihiro Nakajima1, Etsuji Saji1, Takashi Nakajima5, Hiroshi Shimizu2, Yasuko Toyoshima2,7, Hitoshi Takahashi6,8, Akiyoshi Kakita2, Masatoyo Nishizawa4,8, Osamu Onodera1, Izumi Kawachi1,3 (1.Department of Neurology, Brain Research Institute, Niigata University, 2.Department of Pathology, Brain Research Institute, Niigata University, 3.Medical Education Center, Niigata University School of Medicine, 4.Niigata University of Health and Welfare, 5.Department of Neurology, NHO Niigata National Hospital, 6.Niigata Neurosurgical Hospital, 7.Agano Hospital, 8.Brain Research Institute, Niigata University)

[WS20-04-O/P]Ketogenic diet regulates autoimmune neuroinflammation via changes in small intestinal gut microbiome.

Katsuki Yaguchi1,2, Tadashi Takeuchi1,3, Eiji Miyauchi1,4, Masami Kawasumi1, Yumiko Nakanishi1, Tamotsu Kato1, Jigen Sekine1, Shin Maeda2, Hiroshi Ohno1,5 (1.Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., 2.Department of Gastroenterology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan., 3.Department of Microbiology and Immunology, Stanford University School of Medicine, California, USA., 4.Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan., 5.Immunobiology Laboratory, Department of Medical Life Science, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.)

[WS20-05-O/P]Akkermansia muciniphila endorses T cell pathogenicity and invasion to CNS in experimental autoimmune encephalomyelitis

Manu Mallahalli Shanthappa1, Hirohiko Hohjoh2, Daiki Takewaki1, Shinji Oki1, Wakiro Sato1, Takashi Yamamura1 (1.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashicho, Kodaira, Tokyo ., 2.Department of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Ogawahigashicho, Kodaira, Tokyo)

[WS20-10-O/P]CXCL13 producing peripheral helper T cell (Tph) is a crucial pathogenesis in Castleman disease (iMCD)

Kazuyuki Yoshizaki1, Yoshikane Kikushige2, Takuya Harada2, Hiroaki Niiro2, Kazuko Uno3, Atsushi Kawakami4, Tomohiro Koga4 (1.Osaka Univ., 2.Kyushu Univ., 3.Louis Pasteur Center for Medical Research, 4.Nagasaki -Univ.)

[WS20-12-O/P]Identification of PTPN2 as a population-specific susceptibility locus for primary biliary cholangitis through genome-wide association study

Yuki Hitomi1, Yoshihiro Aiba2, Kazuyoshi Ishigaki3, Minoru Nakamura2,4,5 (1.Department of Human Genetics, Research Institute, National Center for Global Health and Medicine, 2.Clinical Research Center, NHO Nagasaki Medical Center, 3.Laboratory for Human Immunogenetics, RIKEN Center for Integrative Medical Sciences, 4.Division of Biomedical Information Analysis, Medical Institute of Bioregulation, Kyushu University, 5.Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences)

[WS20-15-O/P]Development of novel therapy targeting gut microbiota for primary sclerosing cholangitis.

Haruka Okada1, Masataka Ichikawa2, Nobuhiro Nakamoto1, Takanori Kanai1 (1.Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, 2.Division of Gastroenterology, TOkyo Dental College Ichikawa General Hospital)